Literature DB >> 2212944

In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.

B L Rellahan1, L A Jones, A M Kruisbeek, A M Fry, L A Matis.   

Abstract

We have developed a model of peripheral in vivo T cell tolerance that is induced by administration of the protein superantigen staphylococcal enterotoxin B (SEB). Rather than activating V beta 8+ T cells, in vivo administration of SEB induced in them a profound state of anergy. This was shown by their failure to proliferate to subsequent in vitro restimulation with SEB or to anti-V beta 8 antibodies. This unresponsiveness was V beta 8 specific since T cells from SEB-immunized mice responded normally to other antigens. 8 d after SEB administration, there was no reduction in the number of V beta 8+ T cells or in the intensity of V beta 8 T cell receptor (TCR) expression. Although a portion of the V beta 8+ T cells from SEB-primed mice were able to express interleukin 2 receptors (IL-2Rs), they failed to proliferate in response to exogenous IL-2, indicating they were defective in their IL-2 responsiveness. 2-4 wk after SEB administration, there was a reduction of approximately 50% in the number of V beta 8+ cells in immunized compared with control animals. There was, however, no reduction in the level of TCR expression on the remaining V beta 8+ cells. These data demonstrate that proteins that activate T cells in vitro in a V beta-specific manner can induce a state of anergy in peripheral T cells in vivo and may possibly further mediate clonal deletion in a portion of the tolerized cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212944      PMCID: PMC2188615          DOI: 10.1084/jem.172.4.1091

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  50 in total

1.  Suppression of the in vivo humoral and cellular immune response by staphylococcal enterotoxin B (SEB).

Authors:  M Pinto; M Torten; S C Birnbaum
Journal:  Transplantation       Date:  1978-06       Impact factor: 4.939

2.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

3.  T cell signals: tolerance to DNFB is converted to sensitization by a separate nonspecific second signal.

Authors:  R P Cleveland; H N Claman
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

4.  The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.

Authors:  G Ortega; R J Robb; E M Shevach; T R Malek
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

Review 6.  Immunological tolerance.

Authors:  J G Howard; N A Mitchison
Journal:  Prog Allergy       Date:  1975

7.  Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen.

Authors:  J R Battisto; B R Bloom
Journal:  Nature       Date:  1966-10-08       Impact factor: 49.962

8.  Characterization of the stimulator cells in the murine primary mixed leukocyte response.

Authors:  M Minami; D C Shreffler; C Cowing
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

9.  Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.

Authors:  H G Rammensee; R Kroschewski; B Frangoulis
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

10.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin.

Authors:  J R Lamb; B J Skidmore; N Green; J M Chiller; M Feldmann
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more
  98 in total

Review 1.  The contributions of T-cell anergy to peripheral T-cell tolerance.

Authors:  R Lechler; J G Chai; F Marelli-Berg; G Lombardi
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  Identification of a transcytosis epitope on staphylococcal enterotoxins.

Authors:  Jeffrey W Shupp; Marti Jett; Carol H Pontzer
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.

Authors:  A D Wells; M C Walsh; J A Bluestone; L A Turka
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.

Authors:  H Belfrage; M Dohlsten; G Hedlund; T Kalland
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 5.  Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.

Authors:  Roberto Mallone; Gerald T Nepom
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

6.  A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.

Authors:  D E Smilek; D C Wraith; S Hodgkinson; S Dwivedy; L Steinman; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 7.  Molecular mechanisms for adaptive tolerance and other T cell anergy models.

Authors:  Seeyoung Choi; Ronald H Schwartz
Journal:  Semin Immunol       Date:  2007-04-02       Impact factor: 11.130

8.  Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

Authors:  J J Goronzy; P Bartz-Bazzanella; W Hu; M C Jendro; D R Walser-Kuntz; C M Weyand
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.

Authors:  J M Soos; A C Hobeika; E J Butfiloski; J Schiffenbauer; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Superantigen activation and kinetics of cytokines in the Long-Evans rat.

Authors:  W Huang; L D Koller
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.